Sten H. Vermund

Dr. Sten H. Vermund is an Adjunct Professor of Epidemiology (Microbial Diseases) at Yale School of Public Health with extensive cross-appointments including Cancer Prevention and Control, Yale Cancer Center, Yale Institute for Global Health, and the Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative. A news item from August 2024 indicates he was named Dean of USF Health College of Public Health, suggesting a potential dual appointment or recent career transition.

Dr. Vermund's educational background includes:

• PhD in Epidemiology from Columbia University (1990)
• MPhil in Epidemiology from Columbia University (1987)
• MSc in Community Health in Developing Countries from London School of Hygiene and Tropical Medicine (1981)
• DPH from Royal Institute of Public Health and Hygiene (1981)
• MD from Yeshiva University, Albert Einstein College of Medicine (1977)
• BA in Human Biology from Stanford University (1974)

His research focuses on global health challenges in low-resource settings, with particular expertise in HIV/AIDS prevention and treatment, adolescent sexual and reproductive health, maternal and child health, and pandemic response. His seminal work on HIV-HPV interactions influenced global public health policy by motivating changes to CDC AIDS case surveillance definitions and inspiring worldwide integration of cervical cancer screening within HIV/AIDS programs.

Dr. Vermund's recent publications demonstrate engagement with contemporary public health challenges including gender-sensitive HIV care in Uganda, HIV trends in US cities, trauma-informed prevention for displaced youth, and pandemic response for avian influenza and COVID-19. His work spans implementation science, epidemiological research, and health systems strengthening across multiple continents.

Dr. Vermund has received recognition for his contributions to public health, including an honorary Master of Arts degree from Yale University in 2018. His work has directly influenced global health policy and practice, particularly in the integration of cervical cancer screening within HIV/AIDS programs worldwide.

As a collaborator, Dr. Vermund works with diverse researchers across disciplines. His recent grants include capacity-building for public health in Chad, molecular epidemiology for HIV in Kazakhstan, and COVID-19 vaccine studies in Dominican Republic and Connecticut. He has also worked with schools and arts organizations for COVID-19 risk mitigation and institutional safety, demonstrating practical application of his research to real-world settings.